Publications

Hansen S.K., Borland H., Hasholt L.F., Tümer Z., Nielsen J.E., Rasmussen M.A., Nielsen T.T., Stummann T.C., Fog K. and Hyttel P.: Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11. Stem Cell Res. 2016 May;16(3):553-6.

Hansen S.K., Borland H., Hasholt L.F., Tümer Z., Nielsen J.E., Rasmussen M.A., Nielsen T.T., Stummann T.C., Fog K. and Hyttel P.: Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11. Stem Cell Res. 2016 May;16(3):589-92.

Li T., Pires C., Nielsen T.T., Waldemar G., Hjermind L.E., Nielsen J.E., Dinnyes A., Holst B., Hyttel P. and Freude K.K. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1. Stem Cell Research 2016, 16(2):334-337.

Li T., Pires C., Nielsen T.T., Waldemar G., Hjermind L.E., Nielsen J.E., Dinnyes A., Hyttel P. and Freude K.K.: Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1. Stem Cell Research 2016, 16(2):229-232.

Zhou S., Ochalek A., Szczesna K., Avci H.X., Kobolák J., Varga E., Rasmussen M., Holst B., Cirera S., Hyttel P., Freude K.K. and Dinnyés A.: The positional identity of iPSC-derived neural progenitor cells along the anterior-posterior axis is controlled in a dosage-dependent manner by bFGF and EGF. Differentiation.  2016 Jun 16. doi: 10.1016/j.diff.2016.06.002. [Epub ahead of print]

Zhang Y., Schmid B., Nielsen T.T., Nielsen. J.E., Clausen C., Hyttel P., Holst B. and Freude K.K.: Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B. Stem Cell Research 17(1): 148-150, 2016.

Zhang Y., Schmid B., Nielsen T.T., Nielsen. J.E., Clausen C., Hyttel P., Holst B. and Freude K.K.: Generation of a human induced pluripotent stem cell line viaCRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B. Stem Cell Research 17(1): 151-153, 2016.

Nemes C., Varga E., Táncos Z., Bock I., Francz B., Kobolák J. and Dinnyés A.: Establishment of PSEN1 mutant induced pluripotent stem cell (iPSC) line from an Alzheimer's disease (AD) female patient. Stem Cell Research 17(1): 69-71, 2016.

Ochalek A., Nemes C., Varga E., Táncos Z., Kobolák J. and Dinnyés A.: Establishment of induced pluripotent stem cell (iPSC) line from a 57-year old patient with late onset Alzheimer's disease (LOAD). Stem Cell Research 17(1): 72-74, 2016.

Táncos Z., Varga E., Kovács E., Dinnyés A. and Kobolák K.: Establishment of induced pluripotent stem cell (iPSC) line from an 84-year old patient with late onset Alzheimer's disease (LOAD). Stem Cell Research 17(1): 75-77, 2016.

Chandrasekaran A., Varga E., Nemes C., Táncos Z., Kobolák J. and Dinnyés A.: Establishment of induced pluripotent stem cell (iPSC) line from a 63-year old patient with late onset Alzheimer's disease (LOAD). Stem Cell Research 17(1): 78-80, 2016.

Táncos Z., Varga E., Kovács E., Dinnyés A. and Kobolák J.: Establishment of induced pluripotent stem cell (iPSC) line from a 75-year old patient with late onset Alzheimer's disease (LOAD). Stem Cell Research 17(1): 81-83, 2016.

Rasmussen M.A., Hjermind L.E., Hasholt L.F., Waldemar G., Nielsen J.E., Clausen C., Hyttel P. and Holst B.: Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT). Stem Cell Research, 16(1): 70-74, 2016.

Rasmussen M.A., Hjermind L.E., Hasholt L.F., Waldemar G., Nielsen J.E., Clausen C., Hyttel P. and Holst B.: Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT). Stem Cell Research, 16(1): 75-78, 2016.

Rasmussen M.A., Hjermind L.E., Hasholt L.F., Waldemar G., Nielsen J.E., Clausen C., Hyttel P. and Holst B.: Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia. Stem Cell Research, 16(1): 105-109, 2016.

Tubsuwan A., Pires C., Rasmussen M.A., Schmid B., Nielsen J.E., Hjermind L.E., Hall V., Nielsen T.T., Waldermar G., Hyttel P., Clausen C., Kitiyanant N., Freude K.K. and Holst B.: Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer’s disease patient carrying a L150P mutation in PSEN-1. Stem Cell Research, 16(1): 110-112, 2016.

Marthaler A.G., Schmid B., Tubsuwan A., Poulsen U.B., Hyttel P., Nielsen T.T., Nielsen J.E. and Holst B.: Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H271. Stem Cell Research, 16(1): 159-161, 2016.

Marthaler A.G., Schmid B., Tubsuwan A., Poulsen U.B., Engelbrecht A.F., Mau-Holzmann U.A., Hyttel P., Nielsen T.T., Nielsen J.E. and Holst B.: Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196. Stem Cell Research, 16(1): 162-165, 2016.

Marthaler A.G., Schmid B., Tubsuwan A., Poulsen U.B., Hyttel P., Nielsen T.T., Nielsen, J.E. and Holst B.: Generation of Spinocerebellar ataxia type 2 patient-derived iPSC line H266. Stem Cell Research, 16(1): 166-169, 2016.

Marthaler A.G., Schmid B., Tubsuwan A., Poulsen U.B., Engelbrecht A.F., Mau-Holzmann U.A., Hyttel P., Nielsen T.T., Nielsen J.E. and Holst B.: Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271. Stem Cell Research, 16(1): 180-183, 2016.

Marthaler A.G., Schmid B., Tubsuwan A., Poulsen U.B., Hyttel P., Nielsen T.T., Nielsen J.E. and Holst B.: Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H196. Stem Cell Research, 16(1): 199-201, 2016.

Marthaler A.G., Schmid B., Tubsuwan A., Poulsen U.B., Engelbrecht A.F., Mau-Holzmann U.A., Hyttel P., Nielsen T.T., Nielsen J.E. and Holst B.: Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266. Stem Cell Research, 16(1): 202-205, 2016.

Tangprasittipap A., Satirapod C., Jittorntrum B., Lertritanan S., Anurathaphan U., Phanthong P., Borwornpinyo S., Kitiyanant N., Hongeng S.: Generation of iPSC line MU011.A-hiPS from homozygous α-thalassemia fetal skin fibroblasts. Stem Cell Research, Sep. 2015.

Zhou S., Szczesna K., Ochalek A., Kobolák J., Varga E., Nemes C., Chandrasekaran A., Rasmussen M., Cirera S., Hyttel P., Dinnyés A., Freude K.K., and Avci H.X.: Neurosphere Based Differentiation of Human iPSC Improves Astrocyte Differentiation. Stem Cells International, Aug. 2015.

Høffding M.K., Hyttel P: Ultrastructural visualization of the Mesenchymal-to-Epithelial Transition during reprogramming of human fibroblasts to induced pluripotent stem cells. Stem CellResearch, Nov. 2014.

Varga E , Juhász G, Bozsó Z, Penke B, Fulop L, and Szegedi V: Abeta (1-42) Enhances Neuronal Excitability in the CA1 via NR2B Subunit-Containing NMDA Receptors. Neural Plasticity, Sept. 2014.

Rasmussen M.R., Holst B., Tümer Z., Johnsen M.G., Zhou S., Stummann T.C., Hyttel P., and Clausen C.: Transient p53 Suppression Increases Reprogramming of Human Fibroblasts without Affecting Apoptosis and DNA Damage. Stem Cell Reports, Vol. 3, 404–413, September 9, 2014.

Varga ENemes CDavis RPUjhelly OKlincumhom NPolgar ZMuenthaisong SPirity MKDinnyes AGeneration of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system. Exp Cell Res. 2014 Apr 1;322(2):335-44. 

Nemes C, Varga E, Polgar Z, Klincumhom N, Pirity MK, Dinnyes A.: Generation of Mouse Induced Pluripotent Stem Cells by Protein Transduction. Tissue Eng Part C Methods, 2013 Oct 12. Epub 2013 Oct 10. 

Phanthong P, Raveh-Amit H, Li T, Kitiyanant Y, Dinnyes A.: Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells. Biogerontology, 2013 Dec;14(6):591-602. doi: 10.1007/s10522-013-9455-2. Epub 2013 Aug 21.